T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy

Blood

Volumn 96, Issue 1, 2000, Pages 242-249

  Clark, Dawn R ^a   Repping, Sjoerd ^a   Pakker, Nadine G ^a   Prins, Jan M ^a   Notermans, Daan W ^a   Wit, Ferdinand W N M ^a   Reiss, Peter ^a   Danner, Sven A ^a   Coutinho, Roel A ^a   Lange, Joep M A ^a   Miedema, Frank ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL RENEWAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; MALE; PRIORITY JOURNAL; PROLYMPHOCYTE; SEROCONVERSION; T LYMPHOCYTE SUBPOPULATION; THYMUS;

EID: 0034235116     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.242.013k30_242_249     Document Type: Article

References (44)

1. Joshi VV, Oleske JM. Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children: a study of four cases and a review of the literature. Arch Pathol Lab Med. 1985;109:142.
2. Rosenzweig M, Clark DP, Gaulton GN. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS. 1993;7:1601.
3. Grody WW, Fligiel S, Naeim F. Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol. 1985;84:85.
4. Jenkins M, Hanley MB, Moreno MB, Wieder E, McCune JM. Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood. 1998;91:2672.
5. Koka PS, Fraser JK, Bryson Y, et al. Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo. J Virol. 1998;72:5121.
6. Steinberg HN, Crumpacker CS, Chatis PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol. 1991;65:1765.
7. Zauli G, Re MC, Davis B, et al. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood. 1992;79:2680.
8. Clark DR, Ampel NM, Hallett CA, Yedavalli VR, Ahmad N, DeLuca D. Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. J Infect Dis. 1997;176:649.
9. Gill V, Shattock RJ, Scopes J, et al. Human immunodeficiency virus infection impairs hemopoiesis in long-term bone marrow cultures: nonreversal by nucleoside analogues. J Infect Dis. 1997;176:1510.
10. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396: 690.
11. McCune JM, Loftus R, Schmidt DK, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 1998;101:2301.
12. Watanabe Y, Gyotoku J, Katsura Y. Analysis of the development of T cells by transferring precursors into cultured fetal thymus with a microinjector. Thymus. 1989;13:57.
13. Robin C, Bennaceur-Griscelli A, Louache F, Vainchenker W, Coulombel L. Identification of human T-lymphoid progenitor cells in CD34+CD38low and CD34+CD38+ subsets of human cord blood and bone marrow cells using NOD-SCID fetal thymus organ cultures. Br J Haematol. 1999;104:809.
14. Fridkis-Hareli M, Abel L, Globerson A. Patterns of dual lymphocyte development in co-cultures of fetal thymus and lymphohaematopoietic cells from young and old mice. Immunology. 1992;77: 185.
15. Jenkinson E, Franchi L, Kingston R, Owen J. Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro. Eur J Immunol. 1982;12:583.
16. Noorloos A, van Beek A, Melief C. Cryopreservation of cells for immunological typing of non-Hodgin's lymphomas. Cancer Res. 1992;40:2890.
17. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med. 1995;181:1365.
18. Roos MT, de Leeuw NA, Claessen FA, et al. Viro-immunological studies in acute HIV-1 infection. AIDS. 1994;8:1533.
19. Pakker NG, Kroon EDMB, Roos MTL, et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. AIDS. 1999;13:203.
20. Yeoman H, Gress RE, Bare CV, et al. Human bone marrow and umbilical cord blood cells generate CD4+ and CD8+ single-positive T cells in murine fetal thymus organ culture. Proc Natl Acad Sci U S A. 1993;90:10778.
21. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277:112.
22. Kelleher AD, Roggensack M, Emery S, Carr A, French MA, Cooper DA. Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens. Clin Exp Immunol. 1998;113:85.
23. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4:208.
24. Montaner JS, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial: Italy, The Netherlands, Canada and Australia Study. JAMA. 1998;279:930.
25. Notermans DW, Jurriaans S, de Wolf F, et al. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine: ritonavir/3TC/ZDV Study Group. AIDS. 1998;12:167.
26. Weverling GJ, Lange JM, Jurriaans S, et al. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. AIDS. 1998;12:F117.
27. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci U S A. 1990;87:6058.
28. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest. 1995;95:2061.
29. Bucy RP, Hockett RD, Derdeyn CA, et al. Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest. 1999;103:1391.
30. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143.
31. Hober D, Lucas B, Wattre P, Capron A, Haque A. TNF-alpha production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNF-alpha is one of the mediators causing lysis of HIV-infected T4 cells. Clin Immunol Immunopathol. 1992;62:168.
32. Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A. Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS: enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol. 1989;78:329.
33. Hober D, De Groote D, Vanpouille N, et al. Tumor necrosis factor receptor expression in HIV-1-infected CD4+ Tcells. Microbiol Immunol. 1994;38:1005.
34. Benyoucef S, Lion G, Gerard Y, Wattre P, De Groote D, Hober D. Imbalance in cytokine production by whole blood related to presence of cytopathogenic HIV-1 strains in HIV-1-infected patients. Infection. 1998;26:109.
35. Benyoucef S, Hober D, Shen L, et al. TNF alpha production by whole blood from HIV-1 infected patients. Pathol Biol (Paris). 1996;44:393.
36. Maciejewski JP, Weichold FF, Young NS. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol. 1994;153:4303.
37. Zauli G, Vitale M, Gibellini D, Capitani S. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J Exp Med. 1996;183:99.
38. Geissler RG, Ottmann OG, Eder M, Kojouharoff G, Hoelzer D, Ganser A. Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons. Ann Hematol. 1991; 62:151.
39. Lardon F, Snoeck HW, Nijs G, et al. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol. 1994;22:903.
40. Stylianou E, Aukrust P, Kvale D, Muller F, Froland S. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression - down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol. 1999;116:115.
41. Aukrust P, Muller F, Lien E, et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active retroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis. 1999;79:74.
42. Briand G, Barbeau B, Tremblay M. Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology. 1997;228:171.
43. Phipps DJ, Read SE, Piovesan JP, Mills GB, Branch DR. HIV infection in vitro enhances the activity of src-family protein tyrosine kinases. AIDS. 1996;10:1191.
44. Phipps DJ, Yousefi S, Branch DR. Increased enzymatic activity of the T-cell antigen receptor-associated fyn protein tyrosine kinase in asymptomatic patients infected with the human immunodeficiency virus. Blood. 1997;90:3603.